Aurora Cannabis Inc.
TSX:ACB.TODrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $414.85M
- Beta
- 1.34
- P/E (TTM)
- -3.2
- EPS (TTM)
- -$1.31
Volume 0.32M
Average 0.42M
ACB.TO Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Aurora Cannabis Inc.TSX: ACB.TO
Net Margin · Q4 FY2026 · quarter ended Mar 2026
Net margin narrows to -149.7%
Net margin was -149.7% in Q4 FY2026, down 122.6 pp from a year earlier. On a trailing-twelve-month basis it was -12.1%, down 12.6 pp year over year. Over 3 fiscal years it widened by 75.8 pp.
Context
- Net margin widened in 2 of the last 3 fiscal years.
What to watch
Whether net margin reaches the consensus estimate from 4 analysts of -8.3% for the fiscal year ending Mar 2027, up from -38.0% in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -149.7%-151.6 pp QoQ
- Last fiscal yearMar 2026
- -38.0%-38.4 pp YoY
- LTMMar 2026
- -12.1%-12.6 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -122.6 pp | -2.5 pp | +120.1 pp |
| 1 year | -38.4 pp | +29.7 pp | +68.1 pp |
| 3 years | +75.8 pp | +43.3 pp | -32.4 pp |
| 5 years | +44.5 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2026
- -38.0%
- Year-over-year change
- -38.4pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | -38.0% | -38.4pp |
| FY2025 | 2025-03-31 | 0.5% | +26.1pp |
| FY2024 | 2024-03-31 | -25.6% | +88.1pp |
| FY2023 | 2023-03-31 | -113.7% | +662.3pp |
| FY2022 | 2022-06-30 | -776.0% | — |
Net Margin vs competitors
How ACB.TO compares with its peers on the latest reported figures
- ACB.TO's LTM Mar 2026 net margin of -12.1% is the 4th highest of the 8 companies compared; the peer median is -17.2%.
- Its year-over-year change of -12.6 pp is the 6th highest of 8, against a peer median of +4.2 pp.
- Over three fiscal years its change of +75.8 pp compares with a peer median of +129.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 60.8% | +37.4 pp | -74.7 pp | |
| LTM Mar 2026 | 20.9% | +4.2 pp | +165.5 pp | |
| LTM Mar 2026 | -9.2% | -17.9 pp | — | |
| LTM Mar 2026 | -12.1% | -12.6 pp | +75.8 pp | |
| LTM Mar 2026 | -17.2% | +29.5 pp | +1532.6 pp | |
| LTM Mar 2026 | -31.2% | -4.4 pp | +93.3 pp | |
| LTM Mar 2026 | -84.8% | +137.6 pp | +891.3 pp | |
| LTM Mar 2026 | -1377.2% | -288.2 pp | -1276.3 pp | |
| Peer median (excluding ACB.TO) | -17.2% | +4.2 pp | +129.4 pp | |
Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jun 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 221.34M | 233.29M | 270.28M | 343.29M | 320.59M |
| Cost of Revenue | 200.11M | 297.65M | 138.82M | 155.69M | 303.89M |
| Gross Profit | 21.23M | (64.36M) | 131.46M | 187.61M | 16.7M |
| Gross Margin | 9.6% | -27.6% | 48.6% | 54.6% | 5.2% |
| Research & Development | 10.39M | 6.56M | 3.57M | 3.68M | 4.02M |
| Selling, General & Admin | 188.99M | 183.4M | 156.88M | 166.47M | 173.5M |
| Operating Expenses | 252.67M | 189.96M | 177.91M | 182.66M | 179.5M |
| Depreciation & Amortization | 93.66M | 43.57M | 33.07M | 22.55M | 14.19M |
| EBITDA | (1.55B) | (210.74M) | (12.34M) | 51.35M | (162.79M) |
| EBITDA Margin | -702.4% | -90.3% | -4.6% | 15.0% | -50.8% |
| Operating Income | (231.45M) | (254.32M) | (46.45M) | 4.95M | (162.79M) |
| Operating Margin | -104.6% | -109.0% | -17.2% | 1.4% | -50.8% |
| Interest Income | 4.51M | 19M | 12.81M | 11.51M | 5.85M |
| Interest Expense | 71.81M | 39.46M | 14.19M | 8.42M | 1.81M |
| Other Income / Expenses | (1.49B) | (41.1M) | (13.15M) | 15.43M | 106.27M |
| Income Before Tax | (1.72B) | (295.42M) | (59.6M) | 20.38M | (56.52M) |
| Pre-Tax Margin | -777.1% | -126.6% | -22.1% | 5.9% | -17.6% |
| Income Tax Expense | (2.14M) | (20.32M) | (554K) | 4.62M | 2.1M |
| Net Income | (1.72B) | (265.33M) | (69.33M) | 1.59M | (121.76M) |
| Net Margin | -776.0% | -113.7% | -25.6% | 0.5% | -38.0% |
| EPS (Basic) | (79.92) | (8.17) | (1.28) | 0.03 | (2.15) |
| EPS (Diluted) | (79.92) | (8.17) | (1.28) | 0.03 | (2.15) |
| Weighted Avg Shares | 21.49M | 32.27M | 51.26M | 54.88M | 56.71M |
| Weighted Avg Shares (Diluted) | 21.49M | 32.27M | 51.26M | 55.75M | 56.71M |
Aurora Cannabis Inc.
TSX:ACB.TO
Intrinsic Alpha fair value
Locked
Current Price
$6.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.